Ranked #1 in 8 out of the 10 evaluated specialties by U.S. News
MyPatients provides referring primary care providers with secure access to their patients’ information.
Boston Children's has launched the world's 1st program dedicated to offering hand transplants to children who qualify.
Innovation insider is a semi-monthly e-newsletter analyzes innovations at Boston Children’s, other academic medical centers and from industry.
Read the latest blog by a Boston Children's doctor, clinician or staff member.
Support the hospital with a donation that helps kids get the care they need.
A high-grade glioma is a malignant tumor that arises from the brain’s glial cells, which nourish and support neurons. There are two high-grade gliomas: glioblastoma multiforme (grade IV glioma) and anaplastic astrocytoma (grade III glioma). These are aggressive tumors that rapidly infiltrate adjacent healthy brain tissue and, as a result, are difficult to treat.
As you read on, you’ll find detailed information about glioblastoma multiforme and anaplastic astrocytoma. If you would like to read more general information about brain tumors first, see our overview on brain tumors.
How Dana-Farber/Boston Children’s Cancer and Blood Disorders Center approaches glioblastoma multiforme and anaplastic astrocytoma
Your child will be seen by specialists and caregivers at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, an integrated pediatric oncology program through Dana-Farber Cancer Institute and Boston Children’s Hospital that provides—in one specialized program—all the services of both a leading cancer center and a leading pediatric hospital. Dana-Farber/Boston Children’s is a world-renowned destination for children with malignant and non-malignant brain and spinal cord tumors.
Most children diagnosed with glioblastoma multiforme or anaplastic astrocytoma receive surgery and radiation, and in some cases chemotherapy. Our pediatric neuro-oncology and pediatric neurosurgical specialists at Dana-Farber/Boston Children’s Pediatric Brain Tumor Center offer:
The future of pediatrics will be forged by thinking differently, breaking paradigms and joining together in a shared vision of tackling the toughest challenges before us.”